Flexible Epidemiology Model

End-to-end epidemiology models covering incidence, prevalence, diagnosis, treatment and eligibility
We provide epidemiology-driven consulting that anchors strategic decisions in real-world disease burden, patient segmentation and treatment dynamics. Our capabilities span the full spectrum—from foundational epidemiologic assessments to market-impact modeling—integrated seamlessly with clinical, commercial and access strategy Our epidemiology model is essential in drug development, market sizing, pricing and investment decisions. This model estimates the total addressable patient population using clinical and demographic data, and it often serves as the foundation for revenue forecasts, market access strategy and clinical trial planning
Core offerings

Disease landscape mapping	Prevalence, incidence, subpopulation sizing, geographic distribution
Patient flow modeling	Diagnosis rates, treatment algorithms, line-of-therapy transitions
Forecast inputs	Epidemiology-based demand modeling for revenue forecasting and capacity planning
Unmet need quantification	Stratification by disease stage, comorbidity, and sociodemographic factors
Clinical trial planning	Estimates eligible pool for enrollment

Population (Overall/Gender/Age-group/Race)

Growth based on key drivers

Incidence/Prevalence Number and Trend

All studies are well documented with input selection rationale

Patient # by Segments/LoT

Seg 1 1L → 2L….

Seg 2 1L → 2L….

Diagnosed Patient # by Segments/LoT

Treated Patient # by Segments/LoT

Dashboard

Incidence Rate:

Prevalence Rate:

Split by Patient Segments:

R/R or Progression Rate:

Diagnosis Rate:

Treatment Rate:

Compliance Rate:

Global Epidemiology Estimates - Indication A

CAGR (2015-2030): 1.01%

The Flexible Epidemiology Model makes it easy to update with the latest assumptions and data.

KOL Profiling, Ranking, and Influence Mapping

Understand networks of influence among KOLs and HCPs

We help identify, profile, and rank the most influential Key Opinion Leaders (KOLs) across your therapeutic areas. Our KOL Profiling , Ranking and Influence Mapping framework is ideal for medical affairs, commercial strategy, or BD teams looking to engage the right experts and shape their market presence. We provide deep understanding of the KOL clusters through network mapping, tagging the influencers, followers, and equals.

We deliver

Academic & clinical profiles	Assess KOL publications, trials, credentials
Digital footprint	Identify social media influence, congress activity
Network mapping	Which KOL influences whom and how
Global to local tiers	Segment KOLs by region, specialty and subspecialty
Scoring frameworks	Objective ranking of KOLs influence, reach and fit

Entering New TA/Indication

Conduct Clinical Trials

Publishing Articles in Journals

Presentation at Conferences

Improving Product Sales

Recruiting KOL as Consultants

Project executed Only through secondary research – Costly PMR not needed